In summary, this review has explored the relationship between colorectal cancer (CRC) and neuropathy, with a specific focus on chemotherapy-induced peripheral neuropathy (CIPN), highlighting the role of matrix metalloproteinase 9 (MMP9). This evidence concerns the gene MMP9 and colorectal carcinoma.